News (under construction)
2026
Congratulations to Miguel Franquiz, MD, PharmD, on receiving an AHA Postdoctoral Fellowship, which will support his work in the Zhu Lab beginning Summer 2026.
Congratulations to Hiranya Sundar for having her abstract accepted as a poster presentation at the AHA Basic Cardiovascular Sciences (BCVS) Scientific Sessions.
Congratulations to Jiaqi for receiving Best Poster recognition at the Stanford resident research event, and to Han Zhu, MD, for being recognized as a research mentor.
We are thrilled to receive an NIH R01 award to investigate targeted therapeutic approaches for immune checkpoint inhibitor myocarditis, with a focus on preserving anti-tumor immunity while reducing cardiac toxicity.
Congratulations to members of the Zhu Lab for receiving the Circulation Research Best Manuscript Award in Basic Sciences for work identifying the CXCR3–CXCL9/10 axis as a novel therapeutic strategy to treat immune checkpoint inhibitor myocarditis and improve the safety of cancer immunotherapy.
2025
Congratulations to Evaline Cheng, MD, on her promotion to Clinical Assistant Professor at Stanford University.
Congratulations to the team on publication of our work in JACC: CardioOncology titled, “Cardiac Troponin Screening and Clinical Outcomes in Patients Receiving Immunotherapy.”
Congratulations to the team on publication of our work in the Journal of Clinical Investigation demonstrating the use of plasma cell-free mRNA profiling to characterize immune responses and myocardial injury in immune checkpoint inhibitor myocarditis.
The Zhu Lab was honored to receive an AHA Transformational Project Award supporting work on fibroblast–T cell crosstalk in immunotherapy myocarditis.
Congratulations to Yuhsin “Vivian” Huang, BA, and Yin Sun, PhD, on publication of our study, “Novel Therapeutic Approach Targeting CXCR3 to Treat Immunotherapy Myocarditis,” published in Circulation Research.
2024
The Zhu Lab was proud to become an NIH R01-funded laboratory, supporting translational studies using human samples and mouse models to investigate therapeutic pathways in cardiac sarcoidosis.
The lab was also awarded an NIH R03 grant supporting studies of CXCR3-mediated T cell/macrophage crosstalk in immune checkpoint inhibitor myocarditis.
Congratulations to Yin Sun, PhD, on receiving an AHA Postdoctoral Fellowship.
Congratulations to Yin Sun, PhD, for receiving a Best Poster Award at a Stanford Cardiovascular Institute research event for his work in cardio-immunology and tumor-conscious therapeutic targeting.
2023
Congratulations to Vivian Huang for winning the Best Poster Prize at the Stanford-Duke Cardiovascular Research Symposium.
Congratulations to Evaline Cheng, MD, on receiving an NIH F32 Postdoctoral Fellowship to support her work in the Zhu Lab.
Congratulations to Miguel Franquiz for getting his manuscript on osimertinib cardiotoxicity accepted to JACC: CardioOncology.
Congratulations to Vivian Huang for having her abstract accepted as an oral presentation at the AHA Scientific Sessions.
Congratulations to Toni Chan for having her abstract accepted as a poster presentation at the AHA Scientific Sessions.

